341 related articles for article (PubMed ID: 20702813)
41. Transforming Growth Factor
Ji Y; Lisabeth EM; Neubig RR
Mol Pharmacol; 2021 Aug; 100(2):53-60. PubMed ID: 34031187
[TBL] [Abstract][Full Text] [Related]
42. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
[TBL] [Abstract][Full Text] [Related]
43. Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.
Hsu A; Zhang W; Lee JF; An J; Ekambaram P; Liu J; Honn KV; Klinge CM; Lee MJ
Int J Oncol; 2012 May; 40(5):1619-26. PubMed ID: 22344462
[TBL] [Abstract][Full Text] [Related]
44. Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.
Wu JH; Fanaroff AC; Sharma KC; Smith LS; Brian L; Eipper BA; Mains RE; Freedman NJ; Zhang L
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):702-8. PubMed ID: 23288169
[TBL] [Abstract][Full Text] [Related]
45. Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway.
Yang J; Yang L; Tian L; Ji X; Yang L; Li L
Cell Physiol Biochem; 2018; 49(5):1677-1693. PubMed ID: 30231248
[TBL] [Abstract][Full Text] [Related]
46. The actin depolymerizing factor destrin serves as a negative feedback inhibitor of smooth muscle cell differentiation.
Liao KA; Rangarajan KV; Bai X; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H893-H904. PubMed ID: 34559579
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.
Orr Gandy KA; Adada M; Canals D; Carroll B; Roddy P; Hannun YA; Obeid LM
FASEB J; 2013 Aug; 27(8):3155-66. PubMed ID: 23629860
[TBL] [Abstract][Full Text] [Related]
48. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG.
Aurandt J; Vikis HG; Gutkind JS; Ahn N; Guan KL
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12085-90. PubMed ID: 12196628
[TBL] [Abstract][Full Text] [Related]
49. EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells.
Ogita H; Kunimoto S; Kamioka Y; Sawa H; Masuda M; Mochizuki N
Circ Res; 2003 Jul; 93(1):23-31. PubMed ID: 12775584
[TBL] [Abstract][Full Text] [Related]
50. Sphingosine-1-phosphate induces airway smooth muscle cell proliferation, migration, and contraction by modulating Hippo signaling effector YAP.
Liu L; Zhai C; Pan Y; Zhu Y; Shi W; Wang J; Yan X; Su X; Song Y; Gao L; Li M
Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L609-L621. PubMed ID: 29999407
[TBL] [Abstract][Full Text] [Related]
51. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
[TBL] [Abstract][Full Text] [Related]
52. Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF.
Perrot V; Vazquez-Prado J; Gutkind JS
J Biol Chem; 2002 Nov; 277(45):43115-20. PubMed ID: 12183458
[TBL] [Abstract][Full Text] [Related]
53. PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA.
Ying Z; Giachini FR; Tostes RC; Webb RC
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1657-63. PubMed ID: 19759375
[TBL] [Abstract][Full Text] [Related]
54. Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho.
Fukuhara S; Chikumi H; Gutkind JS
FEBS Lett; 2000 Nov; 485(2-3):183-8. PubMed ID: 11094164
[TBL] [Abstract][Full Text] [Related]
55. Reversible translocation of p115-RhoGEF by G(12/13)-coupled receptors.
Meyer BH; Freuler F; Guerini D; Siehler S
J Cell Biochem; 2008 Aug; 104(5):1660-70. PubMed ID: 18320579
[TBL] [Abstract][Full Text] [Related]
56. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.
Arikawa K; Takuwa N; Yamaguchi H; Sugimoto N; Kitayama J; Nagawa H; Takehara K; Takuwa Y
J Biol Chem; 2003 Aug; 278(35):32841-51. PubMed ID: 12810709
[TBL] [Abstract][Full Text] [Related]
57. Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells.
Li Q; Chen B; Zeng C; Fan A; Yuan Y; Guo X; Huang X; Huang Q
Exp Physiol; 2015 Jan; 100(1):95-107. PubMed ID: 25557733
[TBL] [Abstract][Full Text] [Related]
58. Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs.
Castaldi A; Chesini GP; Taylor AE; Sussman MA; Brown JH; Purcell NH
Cell Signal; 2016 Aug; 28(8):871-9. PubMed ID: 27094722
[TBL] [Abstract][Full Text] [Related]
59. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN.
Malchinkhuu E; Sato K; Maehama T; Mogi C; Tomura H; Ishiuchi S; Yoshimoto Y; Kurose H; Okajima F
Biochem Biophys Res Commun; 2008 Feb; 366(4):963-8. PubMed ID: 18088600
[TBL] [Abstract][Full Text] [Related]
60. Detrimental Role of PDZ-RhoGEF in Pathological Cardiac Hypertrophy.
Huang J; Qu Q; Dai Y; Ren D; Qian J; Ge J
Hypertension; 2023 Feb; 80(2):403-415. PubMed ID: 36448462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]